Proteomics-Driven Biomarkers in Pancreatic Cancer

Pancreatic cancer is a devastating disease that has a grim prognosis, highlighting the need for improved screening, diagnosis, and treatment strategies. Currently, the sole biomarker for pancreatic ductal adenocarcinoma (PDAC) authorized by the U.S. Food and Drug Administration is CA 19-9, which pro...

全面介紹

書目詳細資料

發表在:	Proteomes
Main Authors:	Luís Ramalhete, Emanuel Vigia, Rúben Araújo, Hugo Pinto Marques
格式:	Article
語言:	英语
出版:	MDPI AG 2023-08-01
主題:	pancreatic cancer proteomics biomarker chemotherapy effectiveness
在線閱讀:	https://www.mdpi.com/2227-7382/11/3/24